Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Purchased by Sei Investments Co.

Sei Investments Co. raised its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 246.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,411 shares of the medical instruments supplier’s stock after acquiring an additional 3,848 shares during the quarter. Sei Investments Co.’s holdings in Mesa Laboratories were worth $714,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the business. FMR LLC raised its holdings in shares of Mesa Laboratories by 34.1% in the 3rd quarter. FMR LLC now owns 393 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 100 shares in the last quarter. Amundi increased its holdings in shares of Mesa Laboratories by 81.6% in the fourth quarter. Amundi now owns 661 shares of the medical instruments supplier’s stock valued at $91,000 after buying an additional 297 shares in the last quarter. Captrust Financial Advisors bought a new position in shares of Mesa Laboratories in the third quarter valued at $207,000. Berry Wealth Group LP lifted its position in shares of Mesa Laboratories by 5.3% during the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier’s stock valued at $219,000 after acquiring an additional 83 shares during the last quarter. Finally, Quadrature Capital Ltd bought a new stake in shares of Mesa Laboratories during the 3rd quarter worth $221,000. Institutional investors own 90.60% of the company’s stock.

Insider Buying and Selling

In related news, CEO Gary M. Owens sold 21,000 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the completion of the sale, the chief executive officer now directly owns 43,337 shares of the company’s stock, valued at approximately $5,369,887.67. This represents a 32.64 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 4.40% of the company’s stock.

Mesa Laboratories Stock Down 3.5 %

Shares of Mesa Laboratories stock opened at $105.24 on Wednesday. Mesa Laboratories, Inc. has a 12-month low of $83.68 and a 12-month high of $155.12. The firm has a market capitalization of $571.87 million, a PE ratio of -2.27 and a beta of 0.92. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. The stock’s fifty day moving average is $132.09 and its 200-day moving average is $128.55.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 30.23% and a negative net margin of 104.92%. Equities analysts anticipate that Mesa Laboratories, Inc. will post 8 earnings per share for the current year.

Mesa Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be given a $0.16 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.64 annualized dividend and a dividend yield of 0.61%. Mesa Laboratories’s dividend payout ratio (DPR) is presently -1.38%.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.